These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 30604509)
21. Effects of medications on post-endoscopic retrograde cholangiopancreatography pancreatitis. Li N; Tieng A; Novak S; Fernandes A; Jalal PK; Akerman M; Sideridis K; Bank S Pancreatology; 2010; 10(2-3):238-42. PubMed ID: 20484961 [TBL] [Abstract][Full Text] [Related]
22. Effect of somatostatin in the prevention of pancreatic complications after endoscopic retrograde cholangiopancreatography. Chan HH; Lai KH; Lin CK; Tsai WL; Lo GH; Hsu PI; Wei MC; Wang EM J Chin Med Assoc; 2008 Dec; 71(12):605-9. PubMed ID: 19114324 [TBL] [Abstract][Full Text] [Related]
23. Assessment of frequency and safety of endoscopic retrograde cholangiopancreatography in patients over 80 years of age. Talar-Wojnarowska R; Szulc G; Woźniak B; Pazurek M; Małecka-Panas E Pol Arch Med Wewn; 2009 Mar; 119(3):136-40. PubMed ID: 19514642 [TBL] [Abstract][Full Text] [Related]
24. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial. Lee KT; Lee DH; Yoo BM Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260 [TBL] [Abstract][Full Text] [Related]
25. Trends in Post-Therapeutic Endoscopic Retrograde Cholangiopancreatography Gastrointestinal Hemorrhage, Perforation and Mortality from 2000 to 2012: A Nationwide Study. Afridi F; Rotundo L; Feurdean M; Ahlawat S Digestion; 2019; 100(2):100-108. PubMed ID: 30466078 [TBL] [Abstract][Full Text] [Related]
27. Prophylactic rectal indomethacin may be ineffective for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis in general patients: A meta-analysis. Feng Y; Navaneethan U; Zhu X; Varadarajulu S; Schwartz I; Hawes R; Hasan M; Yang A Dig Endosc; 2017 May; 29(3):272-280. PubMed ID: 27914176 [TBL] [Abstract][Full Text] [Related]
28. European Society of Gastrointestinal Endoscopy (ESGE) Guideline: prophylaxis of post-ERCP pancreatitis. Dumonceau JM; Andriulli A; Deviere J; Mariani A; Rigaux J; Baron TH; Testoni PA; Endoscopy; 2010 Jun; 42(6):503-15. PubMed ID: 20506068 [TBL] [Abstract][Full Text] [Related]
29. Surgeon-performed endoscopic retrograde cholangiopancreatography. Outcomes of 2392 procedures at two tertiary care centers. Al-Mansour MR; Fung EC; Jones EL; Zayan NE; Wetzel TD; Martin Del Campo SE; Jalilvand AD; Suzo AJ; Dettorre RR; Fullerton JK; Meara MP; Mellinger JD; Narula VK; Hazey JW Surg Endosc; 2018 Jun; 32(6):2871-2876. PubMed ID: 29273876 [TBL] [Abstract][Full Text] [Related]
30. Complications of endoscopic retrograde cholangiopancreatography. Lal D; Lane M; Wong P N Z Med J; 2003 Jul; 116(1177):U496. PubMed ID: 12861310 [TBL] [Abstract][Full Text] [Related]
31. Comparison between ulinastatin and nafamostat for prevention of post-endoscopic retrograde cholangiopancreatography complications: a prospective, randomized trial. Park JY; Jeon TJ; Hwang MW; Sinn DH; Oh TH; Shin WC; Choi WC Pancreatology; 2014; 14(4):263-7. PubMed ID: 25062874 [TBL] [Abstract][Full Text] [Related]
32. The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis. Okuno M; Shiroko J; Taguchi D; Yamaguchi K; Takada J; Imai S; Sato H; Thanabashi S Intern Med; 2018 Aug; 57(16):2289-2294. PubMed ID: 29607957 [TBL] [Abstract][Full Text] [Related]
33. Effect of somatostatin on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis and hyperamylasemia: A systematic review and meta-analysis. Wang G; Xiao G; Xu L; Qiu P; Li T; Wang X; Wen P; Wen J; Xiao X Pancreatology; 2018 Jun; 18(4):370-378. PubMed ID: 29550097 [TBL] [Abstract][Full Text] [Related]
34. A post-endoscopic retrograde cholangiopancreatography subcapsular hepatic hematoma. Soler Humanes R; Suárez Muñoz MÁ; García García B Rev Esp Enferm Dig; 2017 Nov; 109(11):803. PubMed ID: 29032692 [TBL] [Abstract][Full Text] [Related]
35. Prevention and management of adverse events of endoscopic retrograde cholangiopancreatography. Balmadrid B; Kozarek R Gastrointest Endosc Clin N Am; 2013 Apr; 23(2):385-403. PubMed ID: 23540966 [TBL] [Abstract][Full Text] [Related]
36. Endoscopic retrograde cholangiopancreatography with double balloon enteroscope in patients with altered gastrointestinal anatomy: A meta-analysis. Shao XD; Qi XS; Guo XZ Saudi J Gastroenterol; 2017; 23(3):150-160. PubMed ID: 28611338 [TBL] [Abstract][Full Text] [Related]
37. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial. Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123 [TBL] [Abstract][Full Text] [Related]
38. Complications of endoscopic retrograde cholangiopancreatography: avoidance and management. Freeman ML Gastrointest Endosc Clin N Am; 2012 Jul; 22(3):567-86. PubMed ID: 22748249 [TBL] [Abstract][Full Text] [Related]
39. Association Between Endoscopist and Center Endoscopic Retrograde Cholangiopancreatography Volume With Procedure Success and Adverse Outcomes: A Systematic Review and Meta-analysis. Keswani RN; Qumseya BJ; O'Dwyer LC; Wani S Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1866-1875.e3. PubMed ID: 28606848 [TBL] [Abstract][Full Text] [Related]
40. [Preventive strategy for post-ERCP pancreatitis]. Gu B; Li X; Hu J; Zhang F; Lu J; Chen H Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Feb; 44(2):209-215. PubMed ID: 30837391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]